JPMORGAN CHASE & CO - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$10,904,326
+198.2%
283,819
+79.7%
0.00%
Q1 2023$3,657,000
+91738.3%
157,964
+3.9%
0.00%
-100.0%
Q4 2022$3,982
-99.9%
151,985
-52.0%
0.00%0.0%
Q3 2022$6,229,000
+170.1%
316,831
+140.2%
0.00%
Q2 2022$2,306,000
+5.9%
131,876
-1.0%
0.00%
Q1 2022$2,178,000
+2.6%
133,150
+2.3%
0.00%
Q4 2021$2,122,000
+26.7%
130,165
-0.8%
0.00%
Q3 2021$1,675,000
-26.3%
131,279
-18.4%
0.00%
Q2 2021$2,272,000
-11.6%
160,879
-2.7%
0.00%
Q1 2021$2,569,000
-13.9%
165,266
-12.2%
0.00%
Q4 2020$2,984,000188,1610.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders